Alternative splicing regulation and its therapeutic potential in bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Bladder cancer is a major global health concern with high mortality rates.
• Alternative splicing is a key regulator of gene expression, increasing protein diversity.
• Aberrant alternative splicing is a hallmark of bladder cancer development.

Purpose of the Study:

• To provide a comprehensive review of alternative splicing in bladder cancer.
• To discuss the role of alternative splicing in bladder cancer progression and drug resistance.
• To highlight the therapeutic potential of targeting alternative splicing.

Main Methods:

• Literature review of current research on alternative splicing in bladder cancer.
• Analysis of the regulatory mechanisms of alternative splicing in bladder cancer.
• Examination of the link between splicing factors, gene expression, and bladder cancer.

Main Results:

• Alternative splicing dysregulation is prevalent in bladder cancer.
• Splicing factor abnormalities are associated with bladder cancer progression.
• Altered splicing patterns contribute to drug resistance in bladder cancer.

Conclusions:

• Alternative splicing plays a critical role in bladder cancer pathogenesis.
• Targeting aberrant alternative splicing presents a promising therapeutic strategy for bladder cancer.
• Further research into splicing modulation could lead to novel bladder cancer treatments.